Rimda Wanchoo
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers 9
- Immunology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment 10
- Cancer Research top 1%
- Nephrology top 1%
- Renal Diseases and Glomerulopathies 8
- Chronic Kidney Disease and Diabetes 4
-
- Chronic Lymphocytic Leukemia Research 7
-
- Chronic Myeloid Leukemia Treatments 6
- Multiple Myeloma Research and Treatments 4
-
- Renal Transplantation Outcomes and Treatments 4
- Co-authors
- Kenar D. JhaveriNupur N. UppalVincent Launay‐VacherCraig DevoeValerie S. BartaGilbert DerayVanesa BijolPurva Sharma
- Journals
- SHILAP Revista de lepidopterología (1 paper)Kidney International (6 papers)Journal of the American Society of Nephrology (4 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Rimda Wanchoo
48 papers receiving 12.6k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 9.9k
- Immunology 4.3k
- Pulmonary and Respiratory Medicine 4.0k
- Cancer Research 1.1k
- Nephrology 415
Countries citing papers authored by Rimda Wanchoo
This map shows the geographic impact of Rimda Wanchoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rimda Wanchoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rimda Wanchoo more than expected).
Fields of papers citing papers by Rimda Wanchoo
This network shows the impact of papers produced by Rimda Wanchoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rimda Wanchoo. The network helps show where Rimda Wanchoo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rimda Wanchoo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 0 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 0 | |
| 10 | 2020 | 89 | |
| 11 | 2020 | 246 | |
| 12 | 2020 | 19 | |
| 13 | 2018 | 4 | |
| 14 | 2018 | 28 | |
| 15 | 2017 | 42 | |
| 16 | Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Reviewbreakdown → | 2017 | 11620 |
| 17 | Adverse renal effects of novel molecular oncologic targeted therapies: A review of the FDA Adverse Event Reporting System (FAERS) | 2016 | 6 |
| 18 | 2016 | 58 | |
| 19 | 2015 | 3 | |
| 20 | 2015 | 3 |
About Rimda Wanchoo
Rimda Wanchoo is a scholar working on Nephrology, Transplantation and Hematology, having authored 51 papers that have together received 12.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Renal Diseases and Glomerulopathies (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Renal Transplantation Outcomes and Treatments (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Oncology (9.9k citations), Immunology (4.3k citations) and Pulmonary and Respiratory Medicine (4.0k citations). Rimda Wanchoo has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Kenar D. Jhaveri, Nupur N. Uppal, Vincent Launay‐Vacher, Craig Devoe, Valerie S. Barta, Gilbert Deray, Vanesa Bijol, Purva Sharma, Yuriy Khanin and Hitesh H. Shah. Their work appears in journals such as SHILAP Revista de lepidopterología, Kidney International and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.